Division of Metabolic and Genetic Diseases, Children Hospital Giovanni XXIII, Azienda Ospedaliero-Universitaria Consorziale, 70126 Bari, Italy.
Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", 70126 Bari, Italy.
Nutrients. 2024 Feb 27;16(5):669. doi: 10.3390/nu16050669.
To achieve a normal nutritional status, patients suffering from phenylketonuria (PKU) are typically prescribed amino acid (AA) supplements with low or no phenylalanine (Phe) content. Studies evaluating patient preferences regarding the intake modalities of AA supplements are limited. This study aimed to collect real-world data regarding prescription adherence and intake modalities of AA supplements reported by PKU patients while monitoring metabolic control.
This cross-sectional study included 33 PKU patients (16 female and 17 male) with a mean age of 27.2 years. Questionnaires were provided to assess information on AA supplement intake, such as prescription adherence rate, frequency and timing of administration, supplement formulation, and combination with food or drinks. Plasma phenylalanine levels were monitored during the study period.
51.5% ( = 17) of patients reported to lay within an adherence range of 75-100%. The majority of patients consumed AA supplements twice daily, with breakfast (87.9%) and afternoon snacks (51.5%). Powder supplements were most commonly used (72.7%) and often combined with milk and/or fruit juices (45.4%).
Despite the known concerns related to treatment compliance among PKU adolescents and adults, most of the study participants reported a high level of adherence to AA supplement prescription. The personalized dietary regimens followed by the patients included in the current study represent a treatment approach that might be worth trying in non-compliant patients.
为了达到正常的营养状态,患有苯丙酮尿症(PKU)的患者通常需要服用低苯丙氨酸(Phe)或无苯丙氨酸的氨基酸(AA)补充剂。然而,评估患者对 AA 补充剂摄入方式偏好的研究有限。本研究旨在收集 PKU 患者的实际处方依从性和 AA 补充剂摄入方式的数据,同时监测代谢控制情况。
本横断面研究纳入了 33 名 PKU 患者(16 名女性和 17 名男性),平均年龄为 27.2 岁。问卷调查评估了 AA 补充剂摄入的相关信息,如处方依从率、给药频率和时间、补充剂剂型以及与食物或饮料的组合情况。在研究期间监测了患者的血浆苯丙氨酸水平。
51.5%(=17)的患者报告其依从率在 75-100%范围内。大多数患者每天服用 AA 补充剂两次,早餐(87.9%)和下午小吃时间(51.5%)。最常使用的是粉剂补充剂(72.7%),并且经常与牛奶和/或果汁混合(45.4%)。
尽管 PKU 青少年和成人患者的治疗依从性存在已知问题,但大多数研究参与者报告对 AA 补充剂处方的高度依从性。本研究纳入的患者所遵循的个性化饮食方案代表了一种治疗方法,对于非依从性患者可能值得尝试。